The immunity induced by homologous live-attenuated LSD vaccines usually persists for a minimum period of one year (Photo: Bloomberg)
In a major step, the Indian Council of Agriculture Research (ICAR) has recently entered into an agreement with Biovet Private Ltd. for the commercial production of the indigenous vaccine of Lumpy Skin Disease (LSD) called ‘Lumpi-ProVacind’.
The agreement for transfer of technology is the first of the series of tie-ups that Agrinnovate which is the commercial arm of ICAR has lined up for grant of non-exclusive license of ‘Lumpi-ProVacind’.
Others in the pipeline according to senior scientists are Hester Biosciences Ltd, Indian Immunological Ltd (IIL), which is an arm of NDDB, Haryana Veterinary Vaccine Institute and an organisation in Maharashtra to manufacture
First Published: Sep 18 2022 | 10:38 PM IST